Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 10 citing articles:

Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective
Paul Gougis, Floriane Jochum, Baptiste Abbar, et al.
EClinicalMedicine (2024) Vol. 70, pp. 102536-102536
Open Access | Times Cited: 40
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Rui Han, Changquan Ling, Yuqian Wang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Relative treatment effects of first-line chemotherapy and immunotherapy for hepatocellular carcinoma: A systematic review and meta-analysis
Janak Bahirwani, S. Ahuja, Madhav Changela, et al.
Cancer Pathogenesis and Therapy (2025)
Open Access
Machine learning based radiomic models outperform clinical biomarkers in predicting outcomes after immunotherapy for hepatocellular carcinoma
Mathew Vithayathil, Deniz Koku, Claudia Campani, et al.
Journal of Hepatology (2025)
Open Access
Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab–Treated HCC
Tomomitsu Matono, Toshifumi Tada, Takashi Kumada, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
Ran Qin, Tianqiang Jin, Feng Xu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management
Evangelos Triantafyllou, Cathrin Gudd, Lucia Possamai
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 2
Efficacy comparison of immune combination therapies in subgroups for advanced hepatocellular carcinoma patients: Systematic review and network meta-analysis
Yani Wang, W. Y. Lau, Yafei Li, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0306869-e0306869
Open Access
Multimodal transesophageal echocardiography in the surgical resection of patients with hepatocellular carcinoma and inferior vena cava tumor thrombus
Baochun Lai, Yonghuo Ye, Demetrios Moris, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 6, pp. 2588-2598
Open Access
External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion
Jeong Il Yu, Hee Chul Park, Hyunju Shin, et al.
Radiotherapy and Oncology (2023) Vol. 187, pp. 109841-109841
Open Access
Page 1

Scroll to top